| Ticker Details |
Mannatech, Incorporated Common Stock
Mannatech Inc develops and sells nutritional supplements, topical and skin care products, and weight-management products. Its products portfolio includes Ambrotose complex, Ambrotose AO, NutriVerus, and OsoLean, among others.
|
| IPO Date: |
February 16, 1999 |
| Sector: |
Consumer Staples |
| Industry: |
Personal Products |
| Market Cap: |
$8.43M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 2.76%
|
| Avg Daily Range (30 D): |
$0.20 | 4.14%
|
| Avg Daily Range (90 D): |
$0.25 | 4.06%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.06M |
| Avg Daily Volume (30 D): |
.04M |
| Avg Daily Volume (90 D): |
.02M |
| Trade Size |
| Avg Trade Size (Sh.): |
212 |
| Avg Trade Size (Sh.) (30 D): |
76 |
| Avg Trade Size (Sh.) (90 D): |
77 |
| Institutional Trades |
| Total Institutional Trades: |
107 |
| Avg Institutional Trade: |
$1.02M |
| Avg Institutional Trade (30 D): |
$M |
| Avg Institutional Trade (90 D): |
$M |
| Avg Institutional Trade Volume: |
.01M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.3M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
38.92K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-6.71
|
$.49
|
$-5.94
|
|
Diluted EPS
|
$-6.71
|
$.49
|
$-5.94
|
|
Revenue
|
$106.39M
|
$24.92M
|
$26.64M
|
|
Gross Profit
|
$80.08M
|
$18.86M
|
$20.05M
|
|
Net Income / Loss
|
$-12.73M
|
$.95M
|
$-11.3M
|
|
Operating Income / Loss
|
$.23M
|
$-.18M
|
$-.16M
|
|
Cost of Revenue
|
$26.31M
|
$6.06M
|
$6.58M
|
|
Net Cash Flow
|
$-1.98M
|
$.87M
|
$-.71M
|
|
PE Ratio
|
|
|
|
|
|
|